Can procalcitonin be a new biomarker in prostate cancer? Preliminary results
Abdullah Ilktac, Senad Kalkan, Selahattin Çalışkan, et al.
Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia...
Ramazan Topaktas, Emre Tokuç, Musab Ali Kutluhan, et al.